Limitations of acetaminophen as a reference hepatotoxin for the evaluation of in vitro liver models

Acetaminophen is commonly used as a reference hepatotoxin to demonstrate that in vitro human liver platforms can emulate features of clinical drug-induced liver injury. However, the induction of substantial cell death in these models typically requires acetaminophen concentrations (∼10 mM) far higher than blood concentrations of the drug associated with clinical hepatotoxicity (∼1 mM). Using the cytochrome P450 inhibitor 1-aminobenzotriazole, we show that acetaminophen toxicity in cultured human, mouse, and rat hepatocytes is not dependent on N-acetyl-p-benzoquinonimine formation, unlike the in vivo setting. This finding highlights the limitation of using acetaminophen as a reference hepatotoxin for the evaluation of in vitro liver models. Hence, we make recommendations on the selection of reference hepatotoxins for this purpose.

Authors

Institutions

Publication Details

Journal
Toxicological Sciences
Published
2024-10-14
DOI
https://doi.org/10.1093/toxsci/kfae133
Citations
5
Primary Topic
Drug-Induced Hepatotoxicity and Protection
Type
article
Field-Weighted Citation Impact
2.33

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Limitations of acetaminophen as a reference hepatotoxin for the evaluation of in vitro liver models

Dennis Reddyhoff, Christopher E. Goldring, Rafael Díaz-Nieto, Ciarán Fisher et al.
5 citations
Toxicological Sciences
Drug-Induced Hepatotoxicity and Protection
2.33
article

Limitations of acetaminophen as a reference hepatotoxin for the evaluation of in vitro liver models

Dennis Reddyhoff, Christopher E. Goldring, Rafael Díaz-Nieto, Ciarán Fisher, Ian M. Copple, Rowena Sison‐Young, Iain Gardner, Lucia A Livoti
article en
5 citations

Abstract

Acetaminophen is commonly used as a reference hepatotoxin to demonstrate that in vitro human liver platforms can emulate features of clinical drug-induced liver injury. However, the induction of substantial cell death in these models typically requires acetaminophen concentrations (∼10 mM) far higher than blood concentrations of the drug associated with clinical hepatotoxicity (∼1 mM). Using the cytochrome P450 inhibitor 1-aminobenzotriazole, we show that acetaminophen toxicity in cultured human, mouse, and rat hepatocytes is not dependent on N-acetyl-p-benzoquinonimine formation, unlike the in vivo setting. This finding highlights the limitation of using acetaminophen as a reference hepatotoxin for the evaluation of in vitro liver models. Hence, we make recommendations on the selection of reference hepatotoxins for this purpose.

Toxicological SciencesVol. 203(1)
University of Liverpool (GB), Aintree University Hospitals NHS Foundation Trust (GB), Age UK (GB), Predictive Science (United States) (US)
European Federation of Pharmaceutical Industries and Associations, European Commission, Medical Research Council
Good health and well-being
Openalex Percentile: Top 12%
Drug-Induced Hepatotoxicity and Protection
2.33
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Limitations of acetaminophen as a reference hepatotoxin for the evaluation of in vitro liver models — Dennis Reddyhoff, Christopher E. Goldring, et al. · Toxicological Sciences (2024) | TGRS Research Map | TGRS